{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:34:03Z","timestamp":1793172843649,"version":"4.5.0"},"reference-count":79,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:p>Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2 per 1000 births in 2000 to 5.8 per 1000 births in 2012. Symptoms in neonates may include high-pitched cry, tremors, feeding difficulty, hypertonia, watery stools, and breathing problems. However, little is known about the neurodevelopmental consequences of prenatal opioid exposure in infancy, early childhood, and middle childhood. Even less is known about the cognitive, behavioral, and academic outcomes of children who develop NOWS. We review the state of the literature on the neurodevelopmental consequences of prenatal opioid exposure with a particular focus on studies in which NOWS outcomes were examined. Aiming to reduce the incidence of prenatal opioid exposure in the near future, we highlight the need for large studies with prospectively recruited participants and longitudinal designs, taking into account confounding factors such as socioeconomic status, institutional variations in care, and maternal use of other substances, to independently assess the full impact of NOWS. As a more immediate solution, we provide an agenda for future research that leverages the National Institutes of Health Environmental Influences on Child Health Outcomes program to address many of the serious methodologic gaps in the literature, and we answer key questions regarding the short- and long-term neurodevelopmental health of children with prenatal opioid exposure.<\/jats:p>","DOI":"10.1542\/peds.2019-0128","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T08:32:36Z","timestamp":1566981156000},"source":"Crossref","is-referenced-by-count":161,"title":["Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities"],"prefix":"10.1542","volume":"144","author":[{"given":"Elisabeth","family":"Conradt","sequence":"first","affiliation":[{"name":"Departments of Psychology, Pediatrics, and Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Flannery","sequence":"additional","affiliation":[{"name":"School of Public Health, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy L.","family":"Aschner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Albert Einstein College of Medicine, New York, New York;"},{"name":"Department of Pediatrics, Hackensack Meridian School of Medicine, Seton Hall University, Nutley, New Jersey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Annett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Croen","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente, Oakland, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane S.","family":"Duarte","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute,"},{"name":"Department of Psychiatry, Columbia University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Guille","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Hedderson","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente, Oakland, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Hofheimer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ladd-Acosta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and"},{"name":"Wendy Klag Center for Autism and Developmental Disabilities, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Moreland","sequence":"additional","affiliation":[{"name":"National Crime Victims Research and Treatment Center, Medical University of South Carolina, Columbia, South Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenae M.","family":"Neiderhiser","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Pennsylvania State University, University Park, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby H.N.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Posner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nemours\/Alfred I. duPont Hospital for Children, Wilmington, Delaware; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Savitz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Ondersma","sequence":"additional","affiliation":[{"name":"Merrill Palmer Skillman Institute and Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry M.","family":"Lester","sequence":"additional","affiliation":[{"name":"Brown Center for the Study of Children at Risk and Departments of Psychiatry and Human Behavior and Pediatrics, Alpert Medical School, Brown University, Providence, Rhode Island;"},{"name":"Women and Infants Hospital in Rhode Island, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2019,9,1]]},"reference":[{"issue":"31","key":"2021121018241905000_B1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2021121018241905000_B2","doi-asserted-by":"crossref","first-page":"e20152929","DOI":"10.1542\/peds.2015-2929","article-title":"Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost","volume":"137","author":"Holmes","year":"2016","journal-title":"Pediatrics"},{"issue":"31","key":"2021121018241905000_B3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome - 28 states, 1999-2013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2021121018241905000_B4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","article-title":"Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2021121018241905000_B5","first-page":"1367","volume-title":"Primary Pediatric Care","author":"Finnegan","year":"1992","edition":"2nd ed"},{"issue":"2","key":"2021121018241905000_B6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","article-title":"Neonatal opioid withdrawal syndrome","volume":"41","author":"Sutter","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"2021121018241905000_B7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0163-6383(85)90021-9","article-title":"Behavior of neonates exposed in utero to methadone as assessed on the Brazelton scale","volume":"8","author":"Jeremy","year":"1985","journal-title":"Infant Behav Dev"},{"issue":"2","key":"2021121018241905000_B8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-3476(82)80115-7","article-title":"Children of methadone-maintained mothers: follow-up to 18 months of age","volume":"101","author":"Rosen","year":"1982","journal-title":"J Pediatr"},{"issue":"5","key":"2021121018241905000_B9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-3476(81)80830-X","article-title":"Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications","volume":"98","author":"Wilson","year":"1981","journal-title":"J Pediatr"},{"key":"2021121018241905000_B10","first-page":"287","article-title":"Motoric and attentional behavior in infants of methadone-maintained women","volume":"43","author":"Hans","year":"1983","journal-title":"NIDA Res Monogr"},{"issue":"4","key":"2021121018241905000_B11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0163-6383(90)90021-Y","article-title":"The relations among cry characteristics, demographic variables, and developmental test scores in infants prenatally exposed to methadone","volume":"13","author":"Huntington","year":"1990","journal-title":"Infant Behav Dev"},{"issue":"13","key":"2021121018241905000_B12","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3109\/10826084.2010.484474","article-title":"Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale","volume":"45","author":"Jones","year":"2010","journal-title":"Subst Use Misuse"},{"key":"2021121018241905000_B13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1651-2227.1994.tb13383.x","article-title":"Development after prenatal exposure to cocaine, heroin and methadone","volume":"404","author":"van Baar","year":"1994","journal-title":"Acta Paediatr Suppl"},{"issue":"1","key":"2021121018241905000_B14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00194-0","article-title":"Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes","volume":"63","author":"Johnson","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"2021121018241905000_B15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/jp.2015.22","article-title":"Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine","volume":"35","author":"Bier","year":"2015","journal-title":"J Perinatol"},{"key":"2021121018241905000_B16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.earlhumdev.2017.11.009","article-title":"Prenatal buprenorphine exposure and neonatal neurobehavioral functioning","volume":"117","author":"Velez","year":"2018","journal-title":"Early Hum Dev"},{"key":"2021121018241905000_B17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107","author":"Coyle","year":"2012","journal-title":"Addiction"},{"issue":"5","key":"2021121018241905000_B18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/dev.21532","article-title":"Neonatal abstinence syndrome: neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal","volume":"59","author":"Heller","year":"2017","journal-title":"Dev Psychobiol"},{"issue":"8","key":"2021121018241905000_B19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/10826088609027399","article-title":"The development of children of drug addicts","volume":"21","author":"Bauman","year":"1986","journal-title":"Int J Addict"},{"issue":"4","key":"2021121018241905000_B20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0009922814549545","article-title":"Identification of early developmental deficits in infants with preantal heroin, methadone, and other opioid exposure","volume":"54","author":"Beckwith","year":"2015","journal-title":"Clinical Pediatrics"},{"issue":"4","key":"2021121018241905000_B21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0012162299000511","article-title":"Sequential neuromotor examination in children with intrauterine cocaine\/polydrug exposure","volume":"41","author":"Belcher","year":"1999","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"2021121018241905000_B22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s004310050923","article-title":"Neurodevelopmental outcome after prenatal exposure to opiates","volume":"157","author":"Bunikowski","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2021121018241905000_B23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4603(88)90054-8","article-title":"Neurobehavioral functioning in children exposed to narcotics in utero","volume":"13","author":"Davis","year":"1988","journal-title":"Addict Behav"},{"issue":"2","key":"2021121018241905000_B24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1037\/h0079429","article-title":"Children of methadone-dependent women: developmental outcomes","volume":"63","author":"de Cubas","year":"1993","journal-title":"Am J Orthopsychiatry"},{"issue":"3","key":"2021121018241905000_B25","doi-asserted-by":"crossref","first-page":"e20180562","DOI":"10.1542\/peds.2018-0562","article-title":"Educational disabilities among children born with neonatal abstinence syndrome","volume":"142","author":"Fill","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"2021121018241905000_B26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0306-4603(94)90065-5","article-title":"Cognitive brain potential alterations in boys exposed to opiates: in utero and lifestyle comparisons","volume":"19","author":"Guo","year":"1994","journal-title":"Addict Behav"},{"issue":"3","key":"2021121018241905000_B27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/imhj.1003","article-title":"Postneonatal mental and motor development of infants exposed in utero to opioid drugs","volume":"22","author":"Hans","year":"2001","journal-title":"Infant Ment Health J"},{"key":"2021121018241905000_B28","first-page":"195","article-title":"Developmental consequences of prenatal exposure to methadone","volume-title":"Ann N Y Acad Sci","author":"Hans","year":"1989"},{"issue":"1","key":"2021121018241905000_B29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0306-4603(94)00044-Y","article-title":"Vagal tone regulation during sustained attention in boys exposed to opiates in utero","volume":"20","author":"Hickey","year":"1995","journal-title":"Addict Behav"},{"issue":"1","key":"2021121018241905000_B30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","article-title":"Adverse neurodevelopmental outcome of infants exposed to opiate in-utero","volume":"84","author":"Hunt","year":"2008","journal-title":"Early Hum Dev"},{"key":"2021121018241905000_B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","article-title":"Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes","volume":"185","author":"Kaltenbach","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2021121018241905000_B32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2012.04006.x","article-title":"Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy","volume":"108","author":"Konijnenberg","year":"2013","journal-title":"Addiction"},{"issue":"2","key":"2021121018241905000_B33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000366018","article-title":"Visual selective attention is impaired in children prenatally exposed to opioid agonist medication","volume":"21","author":"Konijnenberg","year":"2015","journal-title":"Eur Addict Res"},{"key":"2021121018241905000_B34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.earlhumdev.2016.08.013","article-title":"Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine","volume":"101","author":"Konijnenberg","year":"2016","journal-title":"Early Hum Dev"},{"issue":"1","key":"2021121018241905000_B35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1749-6632.1998.tb09766.x","article-title":"Effects of in utero exposure to cocaine and\/or opiates on infants\u2019 reaching behavior","volume":"846","author":"LaGasse","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"2021121018241905000_B36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.earlhumdev.2017.11.010","article-title":"Early inhibitory control and working memory abilities of children prenatally exposed to methadone","volume":"116","author":"Levine","year":"2018","journal-title":"Early Hum Dev"},{"issue":"2","key":"2021121018241905000_B37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.75.2.269","article-title":"Factors affecting head growth and intellectual function in children of drug addicts","volume":"75","author":"Lifschitz","year":"1985","journal-title":"Pediatrics"},{"issue":"12","key":"2021121018241905000_B38","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/add.12267","article-title":"Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities","volume":"108","author":"Melinder","year":"2013","journal-title":"Addiction"},{"issue":"5","key":"2021121018241905000_B39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41372-018-0088-9","article-title":"Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome","volume":"38","author":"Merhar","year":"2018","journal-title":"J Perinatol"},{"issue":"6","key":"2021121018241905000_B40","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1542\/peds.113.6.1677","article-title":"The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age","volume":"113","author":"Messinger","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"2021121018241905000_B41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/imhj.1005","article-title":"Children prenatally exposed to substances: gender-related differences in outcome from infancy to 3 years of age","volume":"22","author":"Moe","year":"2001","journal-title":"Infant Ment Health J"},{"issue":"5","key":"2021121018241905000_B42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004703-200210000-00006","article-title":"Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years","volume":"23","author":"Moe","year":"2002","journal-title":"J Dev Behav Pediatr"},{"issue":"3","key":"2021121018241905000_B43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/pr.2015.95","article-title":"Longitudinal cognitive development of children born to mothers with opioid and polysubstance use","volume":"78","author":"Nygaard","year":"2015","journal-title":"Pediatr Res"},{"issue":"2","key":"2021121018241905000_B44","doi-asserted-by":"crossref","first-page":"e20162651","DOI":"10.1542\/peds.2016-2651","article-title":"Neonatal abstinence syndrome and high school performance","volume":"139","author":"Oei","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"2021121018241905000_B45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1017\/S0012162201001219","article-title":"Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors","volume":"43","author":"Ornoy","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"2021121018241905000_B46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","article-title":"The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk for developmental disorders","volume":"140\u2013141","author":"Ornoy","year":"2003","journal-title":"Toxicol Lett"},{"issue":"5","key":"2021121018241905000_B47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0145-2134(96)00014-2","article-title":"The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted","volume":"20","author":"Ornoy","year":"1996","journal-title":"Child Abuse Negl"},{"issue":"3\u20134","key":"2021121018241905000_B48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15295190902844563","article-title":"Emotional availability, parental self-efficacy beliefs, and child development in caregiver-child relationships with buprenorphine-exposed 3-year-olds","volume":"9","author":"Salo","year":"2009","journal-title":"Parenting"},{"key":"2021121018241905000_B49","first-page":"1178221818765773","article-title":"Symptoms associated with attention deficit\/hyperactivity disorder and autism spectrum disorders in school-aged children prenatally exposed to substances","volume":"12","author":"Sandtorv","year":"2018","journal-title":"Subst Abuse"},{"issue":"4","key":"2021121018241905000_B50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00004703-199608000-00005","article-title":"Effects of prenatal exposure to opioids on focused attention in toddlers during free play","volume":"17","author":"Schneider","year":"1996","journal-title":"J Dev Behav Pediatr"},{"issue":"5","key":"2021121018241905000_B51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-3476(76)80822-0","article-title":"Behavioural concomitants of prenatal addiction to narcotics","volume":"89","author":"Strauss","year":"1976","journal-title":"J Pediatr"},{"key":"2021121018241905000_B52","first-page":"3","article-title":"Children of methadone-treated women at five years of age","volume":"11","author":"Strauss","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"2021121018241905000_B53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2767","article-title":"Reasons for rehospitalization in children who had neonatal abstinence syndrome","volume":"136","author":"Uebel","year":"2015","journal-title":"Pediatrics"},{"issue":"6","key":"2021121018241905000_B54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1469-7610.1990.tb00833.x","article-title":"Development of infants of drug dependent mothers","volume":"31","author":"van Baar","year":"1990","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"2021121018241905000_B55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/apa.12210","article-title":"Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy","volume":"102","author":"Sundelin Wahlsten","year":"2013","journal-title":"Acta Paediatr"},{"issue":"3","key":"2021121018241905000_B56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pediatrneurol.2014.11.008","article-title":"Child neuroanatomical, neurocognitive, and visual acuity outcomes with maternal opioid and polysubstance detoxification","volume":"52","author":"Walhovd","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2021121018241905000_B57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1542\/peds.63.1.135","article-title":"The development of preschool children of heroin-addicted mothers: a controlled study","volume":"63","author":"Wilson","year":"1979","journal-title":"Pediatrics"},{"key":"2021121018241905000_B58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1989.tb21017.x","article-title":"Clinical studies of infants and children exposed prenatally to heroin","volume":"562","author":"Wilson","year":"1989","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2021121018241905000_B59","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41372-018-0174-z","article-title":"Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome","volume":"38","author":"Jones","year":"2018","journal-title":"J Perinatol"},{"issue":"5389","key":"2021121018241905000_B60","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1126\/science.282.5389.633","article-title":"Cocaine exposure and children: the meaning of subtle effects","volume":"282","author":"Lester","year":"1998","journal-title":"Science"},{"issue":"4","key":"2021121018241905000_B61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0892-0362(03)00029-1","article-title":"Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana","volume":"25","author":"Fried","year":"2003","journal-title":"Neurotoxicol Teratol"},{"key":"2021121018241905000_B62","first-page":"39","article-title":"Methodological issues in assessing the impact of prenatal drug exposure","volume-title":"Subst Abuse","author":"Konijnenberg","year":"2015"},{"issue":"7","key":"2021121018241905000_B63","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/jp.2017.40","article-title":"Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System","volume":"37","author":"Gomez-Pomar","year":"2017","journal-title":"J Perinatol"},{"issue":"1","key":"2021121018241905000_B64","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-0204","article-title":"Neonatal neurobehavior predicts medical and behavioral outcome","volume":"125","author":"Liu","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2021121018241905000_B65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"2021121018241905000_B66","doi-asserted-by":"crossref","first-page":"529.e1","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2021121018241905000_B67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","article-title":"Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome","volume":"165","author":"Wachman","year":"2014","journal-title":"J Pediatr"},{"key":"2021121018241905000_B68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpeds.2017.07.026","article-title":"Increased DNA methylation of ABCB1, CYP2D6, and OPRM1 genes in newborn infants of methadone-maintained opioid-dependent mothers","volume":"190","author":"McLaughlin","year":"2017","journal-title":"J Pediatr"},{"issue":"13","key":"2021121018241905000_B69","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"2021121018241905000_B70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-018-0045-0","article-title":"Neonatal abstinence syndrome","volume":"4","author":"Coyle","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2021121018241905000_B71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MOP.0000000000000600","article-title":"Environmental influences on child health outcomes, a research program of the National Institutes of Health","volume":"30","author":"Gillman","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2021121018241905000_B72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MOP.0000000000000598","article-title":"Coordination of the Environmental influences on Child Health Outcomes program: so the whole is greater than the sum of its parts","volume":"30","author":"Smith","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2021121018241905000_B73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MOP.0000000000000606","article-title":"Measurement framework for the Environmental influences on Child Health Outcomes research program","volume":"30","author":"Blackwell","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2021121018241905000_B74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MOP.0000000000000601","article-title":"The child health exposure analysis resource as a vehicle to measure environment in the environmental influences on child health outcomes program","volume":"30","author":"Wright","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2021121018241905000_B75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MOP.0000000000000602","article-title":"An Environmental influences on Child Health Outcomes viewpoint of data analysis centers for collaborative study designs","volume":"30","author":"Jacobson","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2021121018241905000_B76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MOP.0000000000000597","article-title":"The institutional development award states pediatric clinical trials network: building research capacity among the rural and medically underserved","volume":"30","author":"Snowden","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"2021121018241905000_B77","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ynstr.2018.08.005","article-title":"Early life stress and environmental influences on the neurodevelopment of children with prenatal opioid exposure","volume":"9","author":"Conradt","year":"2018","journal-title":"Neurobiol Stress"},{"key":"2021121018241905000_B78","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpeds.2018.02.004","article-title":"Advancing the science of children\u2019s positive health in the National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) research program","volume":"196","author":"Forrest","year":"2018","journal-title":"J Pediatr"},{"issue":"2","key":"2021121018241905000_B79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/ADM.0000000000000463","article-title":"Prenatal opioid exposure, neonatal abstinence syndrome\/neonatal opioid withdrawal syndrome, and later child development research: shortcomings and solutions","volume":"13","author":"Jones","year":"2019","journal-title":"J Addict Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-0128\/1077744\/peds_20190128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-0128\/1077744\/peds_20190128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T15:23:43Z","timestamp":1664205823000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/144\/3\/e20190128\/38390\/Prenatal-Opioid-Exposure-Neurodevelopmental"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":79,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,1]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-0128","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736515232.793564742","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,1]]},"article-number":"e20190128"}}